Genedata strives to facilitate knowledge sharing and engaging discussions on best practices in the field of NGS-based biosafety testing and Cell Line Development.
By registering using the form below, you can now stay up to date on future open forum events!
Genedata Selector has already co-hosted two successful open forum events with leading biopharma companies; Bristol Myers Squibb on December 10th, 2020, and Boehringer Ingelheim on April 29th, 2021. Our first event focused on NGS-based biosafety testing, featured talks by experts on the key challenges and opportunities in the field. This event covered NGS-based adventitious virus detection, its impact in accelerating timelines, and the benefits of its implementation during biopharma R&D. Our second event focused on Cell Line Development (CLD). It provided a platform for experts to share their experiences in cell line characterization and multi-omics. Other important themes discussed included the applications of NGS in CLD and digitalization. Both events were an opportunity for knowledge sharing and engaging discussions to share best practices in the field. To continue the exchange of ideas, we will host these events regularly, alternating between NGS-based biosafety testing and Cell Line Development.
Please register below to receive information on upcoming events and indicate your specific interests. We look forward to you joining us at a future open forum!